MaxCyte Statistics
Share Statistics
MaxCyte has 106.61M
shares outstanding. The number of shares has increased by 1.17%
in one year.
| 106.61M |
| 1.17% |
| 0.27% |
| 68.22% |
| 97.6M |
| 538 |
| 0.07% |
Short Selling Information
The latest short interest is 3.61M, so 3.38% of the outstanding
shares have been sold short.
| 3.61M |
| 3.38% |
| 3.4% |
| 2.83 |
Valuation Ratios
The PE ratio is -10.62 and the forward
PE ratio is -3.4.
MaxCyte's PEG ratio is
-1.97.
| -10.62 |
| -3.4 |
| 11.29 |
| 3.6 |
| 2.11 |
| -14.91 |
| -1.97 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MaxCyte.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 10.88,
with a Debt / Equity ratio of 0.09.
| 10.88 |
| 10.32 |
| 0.09 |
| -0.39 |
| -0.62 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $338.83K |
| $-360.13K |
| 114 |
| 0.16 |
| 0.8 |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -62.8% in the
last 52 weeks. The beta is 0.29, so MaxCyte's
price volatility has been higher than the market average.
| 0.29 |
| -62.8% |
| 1.84 |
| 2.96 |
| 37.67 |
| 826,995 |
Income Statement
In the last 12 months, MaxCyte had revenue of 38.63M
and earned -41.05M
in profits. Earnings per share was -0.39.
| 38.63M |
| 31.53M |
| -51.2M |
| -41.05M |
| -46.41M |
| -51.2M |
| -0.39 |
Full Income Statement Balance Sheet
The company has 27.88M in cash and 18.03M in
debt, giving a net cash position of 9.85M.
| 27.88M |
| 18.03M |
| 9.85M |
| -216.85M |
| 219.75M |
| 131.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -27.61M
and capital expenditures -1.65M, giving a free cash flow of -29.26M.
| -27.61M |
| -1.65M |
| -29.26M |
| -0.28 |
Full Cash Flow Statement Margins
Gross margin is 81.62%, with operating and profit margins of -132.54% and -106.29%.
| 81.62% |
| -132.54% |
| -106.29% |
| -106.29% |
| -120.14% |
| -132.54% |
| -75.75% |